Toggle light / dark theme

Scientists identify an important protein that increases “bacterial virulence,” when mutated, changing harmless bacteria to harmful ones.

As far as humans are concerned, bacteria can be classified as either harmful, pathogenic bacteria and harmless or beneficial non-pathogenic bacteria. To develop better treatments for diseases caused by pathogenic bacteria, we need to have a good grasp on the mechanisms that cause some bacteria to be virulent. Scientists have identified genes that cause virulence, or capability to cause disease, but they do not fully know how bacteria evolve to become pathogenic.

To find out, Professor Chikara Kaito and his team of scientists from Okayama University, Japan, used a process called experimental evolution to identify molecular mechanisms that cells develop to gain useful traits, and published their findings in PLoS Pathogens. “We’re excited by this research because no one has ever looked at virulence evolution of bacteria in an animal; studies before us looked at the evolution in cells,” said Prof Kaito.

While there are ways to alleviate some symptoms, there is currently no way to prevent or cure Parkinson’s disease, so the prospect of a one-off treatment that completely eliminates it is certainly an exciting one. While such a therapy remains a while off, scientists have demonstrated an exciting proof of concept in mice, whereby inhibiting a single gene as a one-time treatment eradicated the disease entirely, and kept it at bay for the remainder of their lives.

The research was carried out at the University of California, San Diego (UCSD), and centers on a protein called PTB, which plays a role in which genes are switch on and off in a cell. The team was experimenting with techniques whereby the gene that encodes for PTB is switched off so researchers can determine the flow-on effects of a reduction in the that protein on other cell types, and found peculiar results when working with connective tissue cells called fibroblasts.

In one experiment, the team created a cell line that was permanently lacking PTB, and after a couple of weeks found that there was only a small amount of fibroblasts remaining in the dish, which was brimming with neurons instead. Building on this, the team was able to use a single treatment to inhibit the activity of PTB in mice, which reprogrammed support cells in the brain called astrocytes into neurons that produce the neurotransmitter dopamine.

Leading futurist Tracey Follows has written an article at Forbes on #transhumanism documentary IMMORTALITY OR BUST. Check it out!


Zoltan has a more radical idea of change than almost anything else you are seeing on your TV screens today but the mainstream media continue to miss him. That’s why it’s good to see he has made his own documentary film explaining to a broader audience what he’s doing, how it all works, and why they should be interested in transhumanism at all.

‘Immortality or Bust’, winner of the Breakout Award at the Raw Science Film Festival in Los Angeles, follows Zoltan on his 2 year campaign running for President of the US. The film starts by explaining his passion for this transhumanist cause and shows him building a custom-made Bluebird motorhome like his father drove when he was a kid, turning it into a mobile coffin to take him on his journey to Washington DC. There he is to deliver his Transhumanist Bill of Rights.

The audio of the fascinating talks & panel at the Future Day Melbourne 2020 / Machine Understanding event:

Kevin Korb — https://archive.org/searchresults.php Wilkins — https://archive.org/details/john-wilkins-humans-as-machines (John, sorry about the audio — also do you have the slides for this?) Hugo de Garis — https://archive.org/details/hugo-de-garis-future-day-2020 Panel — https://archive.org/…/future-day-panel-kevin-korb-hugo-de-g…

The video will be uploaded at a later date.


Are you for Ethical Ai Eric Klien?


Jess Whittlestone at the Leverhulme Centre for the Future of Intelligence at the University of Cambridge and her colleagues published a comment piece in Nature Machine Intelligence this week arguing that if artificial intelligence is going to help in a crisis, we need a new, faster way of doing AI ethics, which they call ethics for urgency.

For Whittlestone, this means anticipating problems before they happen, finding better ways to build safety and reliability into AI systems, and emphasizing technical expertise at all levels of the technology’s development and use. At the core of these recommendations is the idea that ethics needs to become simply a part of how AI is made and used, rather than an add-on or afterthought.

Ultimately, AI will be quicker to deploy when needed if it is made with ethics built in, she argues. I asked her to talk me through what this means.